Chang‐Fu Kuo
Impact in
- Nephrology top 0.2%
- Gout, Hyperuricemia, Uric Acid
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Nephrology 25
- Gout, Hyperuricemia, Uric Acid 24
- Rheumatology 45
- Rheumatoid Arthritis Research and Therapies 22
- Systemic Lupus Erythematosus Research 18
- Co-authors
- Michael DohertyWeiya ZhangMatthew J. GraingeLai‐Chu SeeKuang‐Hui YuShue‐Fen LuoI‐Jun ChouShang‐Hung Chang
- Journals
- Journal of Clinical Medicine (9 papers)Lara D. Veeken (9 papers)Clinical Rheumatology (7 papers)Oncotarget (6 papers)Annals of the Rheumatic Diseases (6 papers)
- Partner nations
- TaiwanUnited KingdomUnited States
In The Last Decade
Chang‐Fu Kuo
183 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Nephrology 1.6k
- Internal Medicine 355
- Rheumatology 1.3k
- Health Informatics 58
- Cardiology and Cardiovascular Medicine 844
Countries citing papers authored by Chang‐Fu Kuo
This map shows the geographic impact of Chang‐Fu Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Fu Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Fu Kuo more than expected).
Fields of papers citing papers by Chang‐Fu Kuo
This network shows the impact of papers produced by Chang‐Fu Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Fu Kuo. The network helps show where Chang‐Fu Kuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang‐Fu Kuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 33 | |
| 14 | 2021 | 38 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 10 | |
| 17 | 2019 | 25 | |
| 18 | Global epidemiology of gout: prevalence, incidence and risk factors Hit paper breakdown → | 2015 | 830 |
| 19 | 2013 | 15 | |
| 20 | 2012 | 1 |
About Chang‐Fu Kuo
Chang‐Fu Kuo is a scholar working on Nephrology, Rheumatology, Health Informatics, Internal Medicine and Hepatology, having authored 188 papers that have together received 5.4k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (24 papers), Rheumatoid Arthritis Research and Therapies (22 papers), Systemic Lupus Erythematosus Research (18 papers), Atrial Fibrillation Management and Outcomes (18 papers), Case Reports on Hematomas (11 papers), Cardiac Arrhythmias and Treatments (9 papers), Hepatitis C virus research (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). The work is most often cited by research in Nephrology (1.6k citations), Internal Medicine (355 citations), Rheumatology (1.3k citations), Health Informatics (58 citations) and Cardiology and Cardiovascular Medicine (844 citations). Chang‐Fu Kuo has collaborated with scholars based in Taiwan, United Kingdom and United States. Frequent co-authors include Michael Doherty, Weiya Zhang, Matthew J. Grainge, Lai‐Chu See, Kuang‐Hui Yu, Shue‐Fen Luo, I‐Jun Chou, Shang‐Hung Chang, Meng‐Jiun Chiou and Christian Mallen. Their work appears in journals such as Journal of Clinical Medicine, Lara D. Veeken, Clinical Rheumatology, Oncotarget and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.